The news signaled progress against the novel coronavirus that has infected more than 41 million globally, including 8 million Americans and comes 10 days before a U.S. presidential election that may hinge on plans https://www.reuters.com/article/us-usa-election/biden-warns-on-coronavirus-surge-trump-heads-to-florida-in-campaign-sprint-idUSKBN2781A4 to fight the pandemic. AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial. J&J paused its large, late-stage trial last week after a study participant became ill.
I don’t believe in edge. I think it’s a fairy tale. The world is too competitive. Going back to AI, investing is where chess was in 1996, when there was an enormous race between human grandmasters and algorithms, and Deep Blue started to beat Garry Kasparov by using brute compute force. The above is from this interview with Gavin Baker, […]
Earlier Friday morning, it was reported that Tesla Inc (NASDAQ: TSLA) would be recalling 30,000 Model S and X vehicles in China. This was due to suspension issues and was being forced by the Chinese government. Now, a letter obtained by Electrek shows Tesla thinks there is no defect, and no recall is needed.The letter is from Elizabeth H. Mykytiuk, Tesla's managing counsel for regulatory affairs, shows Tesla didn't think the recall was necessary, but it was the easier choice when compared with battling through China's regulatory body that asked for the recall."Due to the opinion of SAMR/DPAC that the topic required a recall in the China market, Tesla was left with the choice of either voluntarily recalling the subject vehicles or carrying a heavy burden through the Chinese administrative process," the letter reportedly reads. "While Tesla disagrees with the opinion of SAMR/DPAC, the Company has decided not to dispute a recall for the China market only."Tesla said that the failure pointed out by Chinese regulators happened in less than 0.05% of vehicles outside of China vs about 0.1% of vehicles in China. Electrek reported in 2016 that the NHTSA has investigated a potential issue in Tesla's Model S and Model X suspension, but they didn't find any defect.Photo courtesy of Tesla.See more from Benzinga * Options Trades For This Crazy Market: Get Benzinga Options to Follow High-Conviction Trade Ideas * Tesla Hacker Discovers New Radar, Ultrasonic Sensors, More * GM Reportedly Does Not Yet Have A Working Hummer EV(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of Intel fell 10% on Friday, a day after reporting disappointing third-quarter results. Jared Blikre breaks down the stock's price action, and discusses what the state of chipmaker means for the rest of the industry.
The news signaled progress against the novel coronavirus that has infected more than 41 million globally, including 8 million Americans and comes 10 days before a U.S. presidential election that may hinge on plans https://www.reuters.com/article/us-usa-election/biden-warns-on-coronavirus-surge-trump-heads-to-florida-in-campaign-sprint-idUSKBN2781A4 to fight the pandemic. AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial. J&J paused its large, late-stage trial last week after a study participant became ill.
